Results 11 to 20 of about 12,408 (263)

Efficacy and Safety of Combined Autologous Blood and Minocycline Pleurodesis for Intractable Pneumothorax in High-Risk Non-Surgical Patients: A Case Series. [PDF]

Respirol Case Rep
This case series suggests that sequential, non‐mixed autologous blood plus minocycline pleurodesis is a feasible option for intractable secondary spontaneous pneumothorax (SSP) in high‐risk, nonsurgical patients, many of whom had ILD and/or severe COPD.
Koh E, Sekine Y.
europepmc   +2 more sources

Pleurodesis: A review of the indications, techniques, and complications

Journal of Association of Pulmonologist of Tamil Nadu, 2021
Pleurodesis is a procedure which obliterates the pleural cavity with the intent of preventing reaccumulation of fluid or air in the pleural cavity.
Venkata Nagarjuna Maturu, Narendra Kumar Narahari   +1 more
doaj   +1 more source

Successful Combined Autologous Blood and Minocycline Pleurodesis for Intractable Bilateral Pneumothorax in an Elderly Patient With Combined Pulmonary Fibrosis and Emphysema: A Case Report. [PDF]

Respirol Case Rep
We describe reproducible, complication‐free control of bilateral pneumothoraces in an octogenarian with CPFE using combined autologous blood and minocycline pleurodesis. ABSTRACT Bilateral pneumothorax in elderly patients with combined pulmonary fibrosis and emphysema (CPFE) is rare and often precludes surgery.
Koh E.
europepmc   +2 more sources

Synergistic Sealing of the Pleural Space: Combining Thoracoscopic Talc Poudrage and IPC for Malignant Pleural Effusion-A Case Series. [PDF]

Respirol Case Rep
We describe the technique of performing talc poudrage and indwelling pleural catheter (IPC) insertion during the same setting to enhance procedural efficiency and patient outcomes. We report a case series of malignant pleural effusion demonstrating successful pleurodesis within 2–4 weeks using this combined approach.
Mohamad Jailaini MF, Azmel AA, Mohd Zain MZ, Abdul Hamid MF.   +3 more
europepmc   +2 more sources

Persistent Low-Output Neonatal Chylothorax: How Long Are We Justified to Wait for Pleurodesis in Partial Responders? [PDF]

Pediatr Pulmonol
ABSTRACT Aims The aim of our study was to review our experience regarding the management of neonatal chylothorax, with particular focus on outcomes of partial responders. Methods We conducted a retrospective analysis of neonatal chylothorax cases between January 2015 and December 2023.
Rollo G, Zarfati A, Burini G, Valfre L, Iacusso C, Capolupo I, Iacobelli BD, Bagolan P, Conforti A, Fusaro F.   +9 more
europepmc   +2 more sources

THE ECONOMIC RATIONALE FOR THE USE OF OUTPATIENT PLEURODESIS IN THE TREATMENT OF MALIGNANT PLEURAL EFFUSIONS

Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, 2020
Introduction. Exudative tumor pleurisy affects up to 100 000 people a year in Russia, up to 400 000 people a year in Europe. Inpatient treatment of such patients is associated with certain costs, and there are also queues for treatment in oncology ...
O. V. Ivanov, V. N. Klimenko, A. V. Reshetov   +2 more
doaj   +1 more source

Intrapleural Administration of Hypotonic Cisplatin for Patients With Malignant Pleural Effusions and Non-Expandable Lungs. [PDF]

Thorac Cancer
Intrapleural administration of hypotonic cisplatin (HPT) decreased or stabilized pleural effusions and was well tolerated in patients with malignant pleural effusion and non‐expandable lungs. ABSTRACT Background/Objectives Thoracostomy and pleurodesis are the mainstay of management for malignant pleural effusions (MPEs). However, pleurodesis may not be
Mori W, Mimori T, Ito J, Sorimachi S, Fujioka S, Hirakawa H, Masui Y, Miyawaki T, Shukuya T, Takahashi K.   +9 more
europepmc   +2 more sources

Indwelling pleural catheters for non-malignant pleural effusions: report on a single centre's 10 years of experience [PDF]

, 2020
BACKGROUND: Recurrent pleural effusion is a common cause of dyspnoea, cough and chest pain during the course of infectious pleurisy and non-malignant diseases like congestive heart failure (CHF) or liver cirrhosis with hepatic hydrothorax (HH). With
Brünger, Martin, Frost, Nikolaj, Raspe, Matthias, Ruwwe-Glösenkamp, Christoph, Suttorp, Norbert, Temmesfeld-Wollbrück, Bettina, Witzenrath, Martin   +6 more
core   +1 more source

Impact of postoperative pleurodesis on pulmonary function after lung segmentectomyCentral MessagePerspective

JTCVS Open, 2021
Objective: Pleurodesis is among several treatment strategies for postoperative alveolo-pleural fistula (APF) after lung resection. Accordingly, the present study aimed to determine the influence of pleurodesis on postoperative pulmonary function. Methods:
Atsushi Kagimoto, MD, Yasuhiro Tsutani, MD, PhD, Yuya Hirai, MD, Yoshinori Handa, MD, PhD, Takahiro Mimae, MD, PhD, Yoshihiro Miyata, MD, PhD, Morihito Okada, MD, PhD   +6 more
doaj   +1 more source

Pleural fluid CRP, LDH, and pH as predictors of successful pleurodesis in malignant pleural effusions

Egyptian Journal of Chest Disease and Tuberculosis, 2015
Background: Pleurodesis fails in 10–40% of patients with recurrent malignant pleural effusions (MPEs) and dyspnea. An accurate definition of the different characteristics of the patient would help to identify more precisely the population mostly ...
Samah M. Shehata, Ashraf E. Sileem, Kareem M. El-Fakharany   +2 more
doaj   +1 more source